Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Stopped Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes

Conditions

• HIV Infections
• Peripheral Nervous System Diseases
• Pain

Interventions

• DRUG: Capsaicin Dermal Patch

Sponsor

NeurogesX